PIPELINE

TRC1051

INDICATION
Angiosarcoma
PHASE 3
RCC, HCC, GTN
PHASE 2
Lung, Breast
PHASE 1

TRC102

INDICATION
GBM, Mesothelioma
PHASE 2
Lung, Solid Tumors
PHASE 1

DE-122

INDICATION
Wet AMDSanten2
PHASE 2

TRC253

INDICATION
ProstateJanssen3
PHASE 2

TRC694

INDICATION
Myeloma
PRE-CLINICAL

TRC205

INDICATION
Fibrosis
PRE-CLINICAL

1 Commercial rights in greater China licensed to Ambrx
2 Partnered with Santen Pharmaceutical Co., Ltd.
3 Janssen Pharmaceuticals retains a buyback option